Transplant-associated thrombotic microangiopathy: opening Pandora's box. (Q30235311)

11 June 2017

title

Transplant-associated thrombotic microangiopathy: opening Pandora's box. (English)

1 reference

11 June 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

Achilles Anagnostopoulos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

author name string

E Gavriilaki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

R A Brodsky

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

13 March 2017

1 reference

Bone Marrow Transplantation

11 June 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1355-1360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287636 AND SRC:MED&resulttype=core&format=json

Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis

31 May 2020

cites work

1 reference

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

21 January 2018

1 reference

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

21 January 2018

1 reference

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

21 January 2018

1 reference

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

21 January 2018

1 reference

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy

21 January 2018

1 reference

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome

21 January 2018

1 reference

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)

21 January 2018

1 reference

Terminal Complement Blockade after Hematopoietic Stem Cell Transplantation Is Safe without Meningococcal Vaccination.

21 January 2018

1 reference

Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.

21 January 2018

1 reference

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

21 January 2018

1 reference

Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria

21 January 2018

1 reference

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.

21 January 2018

1 reference

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

21 January 2018

1 reference

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver

21 January 2018

1 reference

Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis

21 January 2018

1 reference

Clinical management of aplastic anemia

21 January 2018

1 reference

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

21 January 2018

1 reference

Clinical significance of fragmented red cells after allogeneic bone marrow transplantation

21 January 2018

1 reference

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

21 January 2018

1 reference

Diagnosis and management of complement mediated thrombotic microangiopathies

21 January 2018

1 reference

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

21 January 2018

1 reference

Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation

21 January 2018

1 reference

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

21 January 2018

1 reference

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

21 January 2018

1 reference

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome

21 January 2018

1 reference

Genetics and complement in atypical HUS.

21 January 2018

1 reference

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

21 January 2018

1 reference

STUDIES ON DESTRUCTION OF RED BLOOD CELLS. II. CHRONIC HEMOLYTIC ANEMIA WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CERTAIN IMMUNOLOGICAL ASPECTS OF THE HEMOLYTIC MECHANISM WITH SPECIAL REFERENCE TO SERUM COMPLEMENT.

21 January 2018

1 reference

Modified Ham test for atypical hemolytic uremic syndrome

21 January 2018

1 reference

Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome

21 January 2018

1 reference

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.

21 January 2018

1 reference

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

21 January 2018

1 reference

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement

21 January 2018

1 reference

Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium

21 January 2018

1 reference

Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide.

21 January 2018

1 reference

Endothelial dysfunction and altered mechanical and structural properties of resistance arteries in a murine model of graft-versus-host disease.

21 January 2018

1 reference

Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated With Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase

21 January 2018

1 reference

Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen

21 January 2018

1 reference

Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation

21 January 2018

1 reference

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

21 January 2018

1 reference

Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation

21 January 2018

1 reference

Transplantation-associated thrombotic microangiopathy: twenty-two years later

21 January 2018

1 reference

Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer

21 January 2018

1 reference

Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

21 January 2018

1 reference

Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant

21 January 2018

1 reference

A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab

21 January 2018

1 reference

Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

21 January 2018

1 reference

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

21 January 2018

1 reference

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.

21 January 2018

1 reference

Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease

21 January 2018

1 reference

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.

21 January 2018

1 reference

The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.

21 January 2018

1 reference

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

7 January 2021

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

7 January 2021

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation

1 reference

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

7 January 2021

low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens

1 reference

7 January 2021

Typical Hus: Evidence of Acute Phase Complement Activation from a Daycare Outbreak.

1 reference

7 January 2021

Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine

1 reference

7 January 2021

Apoptosis in endothelial cells by cyclosporine

1 reference

7 January 2021

Effects of cyclosporine on metalloproteinase in endothelial cells

1 reference

7 January 2021

Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling

1 reference

7 January 2021

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

1 reference

7 January 2021

Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

1 reference

7 January 2021

Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment

1 reference

7 January 2021

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

1 reference

7 January 2021

Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab

1 reference

7 January 2021

Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases.

1 reference

12 December 2020

The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients

1 reference

12 December 2020

Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.

1 reference

12 December 2020

Renal and neurological response with eculizumab in a patient with transplant associated thrombotic microangiopathy after allogeneic hematopoietic progenitor cell transplantation

1 reference

12 December 2020

Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

1 reference

12 December 2020

Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.

1 reference

12 December 2020

Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.

1 reference

12 December 2020

Endothelial-cell injury in cutaneous acute graft-versus-host disease.

1 reference

12 December 2020

Cyclosporine inhibits prostacyclin production by cultured human endothelial cells

1 reference

12 December 2020

Effects of rapamycin and tacrolimus on mature endothelial cells and endothelial progenitor cells

1 reference

12 December 2020

Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation

1 reference

12 December 2020

Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.

1 reference

12 December 2020